Your browser doesn't support javascript.
loading
Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
van der Sluis, Ronald J; van den Aardweg, Tim; Reuwer, Anne Q; Twickler, Marcel T; Boutillon, Florence; Van Eck, Miranda; Goffin, Vincent; Hoekstra, Menno.
Afiliação
  • van der Sluis RJ; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • van den Aardweg T; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Reuwer AQ; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Twickler MT; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Boutillon F; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Van Eck M; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Goffin V; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
  • Hoekstra M; Division of BiopharmaceuticsGorlaeus Laboratories, Leiden Academic Centre for Drug Research, Einsteinweg 55, 2333CC Leiden, The NetherlandsLaboratory for Microbiology and Infection ControlAmphia Hospital, Breda, The NetherlandsDepartment EndocrinologyDiabetology and Metabolic Diseases, Antwerp Unive
J Endocrinol ; 222(3): 341-50, 2014 Sep.
Article em En | MEDLINE | ID: mdl-25063756
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores da Prolactina / Aterosclerose / Metabolismo dos Lipídeos Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores da Prolactina / Aterosclerose / Metabolismo dos Lipídeos Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article